Literature DB >> 24865892

Theoretical model of critical issues in informed consent in HIV vaccine trials.

Cindi A Lewis1, Stephen Dewhurst, James M McMahon, Catherine A Bunce, Michael C Keefer, Amina P Alio.   

Abstract

The informed consent process (ICP) for HIV vaccine trials poses unique challenges and would benefit from improvements to its historically based structure and format. Here, we propose a theoretical framework that provides a basis for systematically evaluating and addressing these challenges. The proposed framework follows a linear pathway, starting with the precondition of voluntariness, three main variables of valid decision-making (competency, provision of information and understanding) and then the consequential outcome of either refusal or consent to participate. The existing literature reveals that culturally appropriate provision of information and resultant understanding by the vaccine trial participant are among the most significant factors influencing the authenticity of valid decision-making, though they may be overridden by other considerations, such as individual altruism, mistrust, and HIV-related stigma. Community collaborations to foster bidirectional transmission of information and more culturally tailored consenting materials, therefore, represent a key opportunity to enhance the ICP. By providing a visual synopsis of the issues most critical to IC effectiveness in a categorical and relational manner, the framework provided here presents HIV vaccine researchers a tool by which the ICP can be more systematically evaluated and consequently improved.

Entities:  

Keywords:  HIV; HIV vaccine; HIV vaccine trials; informed consent; theoretical models

Mesh:

Substances:

Year:  2014        PMID: 24865892      PMCID: PMC4122591          DOI: 10.1080/09540121.2014.920074

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  63 in total

Review 1.  Taking informed consent seriously in global HIV vaccine research.

Authors:  Wendy K Mariner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-02-01       Impact factor: 3.731

2.  Ethics in clinical research: need for assessing comprehension of informed consent form?

Authors:  Nusrat Shafiq; Samir Malhotra
Journal:  Contemp Clin Trials       Date:  2010-12-10       Impact factor: 2.226

3.  Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.

Authors:  Robert Klitzman
Journal:  Dev World Bioeth       Date:  2008-12       Impact factor: 2.294

Review 4.  Is informed consent broken?

Authors:  Gail E Henderson
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

Review 5.  Informed consent: a critical part of modern medical research.

Authors:  Charles W Lidz
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

6.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

7.  Are there adverse consequences of quizzing during informed consent for HIV research?

Authors:  J Sugarman; A Corneli; D Donnell; T Y Liu; S Rose; D Celentano; B Jackson; A Aramrattana; L Wei; Y Shao; F Liping; R Baoling; B Dye; D Metzger
Journal:  J Med Ethics       Date:  2011-06-08       Impact factor: 2.903

8.  "Once I begin to participate, people will run away from me": understanding stigma as a barrier to HIV vaccine research participation in Kenya.

Authors:  Laura Nyblade; Sagri Singh; Kim Ashburn; Laura Brady; Joyce Olenja
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

9.  Enhancing HIV vaccine trial consent preparedness among street drug users.

Authors:  Celia B Fisher
Journal:  J Empir Res Hum Res Ethics       Date:  2010-06       Impact factor: 1.742

10.  Evaluation of the ability of clinical research participants to comprehend informed consent form.

Authors:  S Bhansali; N Shafiq; S Malhotra; P Pandhi; Inderjeet Singh; S P Venkateshan; S Siddhu; Y P Sharma; K K Talwar
Journal:  Contemp Clin Trials       Date:  2009-03-31       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.